|
Characteristic
|
Number
|
%
|
|---|
|
Age at diagnosis
|
|
≥50
|
23
|
69.7
|
|
<50
|
10
|
30.3
|
|
Histological grade
|
|
1
|
0
|
0
|
|
2
|
20
|
60.6
|
|
3
|
13
|
39.4
|
|
Tumor size
|
|
<2 cm
|
6
|
18.2
|
|
2–5 cm
|
25
|
75.8
|
|
≥5 cm
|
2
|
6.1
|
|
ER status
|
|
ER positive
|
23
|
69.7
|
|
ER negative
|
10
|
30.3
|
|
PgR status
|
|
PgR positive
|
19
|
57.6
|
|
PgR negative
|
14
|
42.4
|
|
HER2 status
|
|
HER2 positive
|
5
|
15.2
|
|
HER2 negative
|
28
|
84.8
|
- Whole tissue serial sections of core biopsies from different regions of the same cancer were prepared and multiple fields of view (FOV) were assessed in each section
-
ER estrogen receptor, PgR progesterone receptor. HER2 human epidermal growth factor receptor 2
